Angiolite

Coronary sirolimus stent

The DES we trust

PRODUCT FEATURES

 

Excellent performance even in compromised situations

Left Main and bifurcation lesions: One of the highest overexpansion capacity for large vessels

​

6.00mm​​

75​µm
​

Small vessels:
Adapted to the need of the arteries with thin struts

Diffuse lesions:
new available lengths


44 &
49mm​​

Calcified lesions:

excellent arterial support

+40%

vs competitors

​

High quality of healing

TransferWise, the iVascular proprietary technology that provides a homogenous drug elution that translates into lower rates of restenosis and inflammation score. Our fluoro-acrylate polymer provides an early endothelialization and creates a thromboresistant layer. This mechanism suggest to reduce stent thrombosis.

Clinical Support

 

Angiolite has proven its safety and efficacy in the following clinical trials and registries

ANCHOR Study

Observational, prospective, multicenter study​

86.3% Strut coverage  

at 3 months​

ANGIOLITE Trial ​

Randomized, non-inferiority, observational, prospective, multicenter trial

0.04mm LLL

at 6 months​

RANGO Registry

Prospective, single arm, multicenter observational registry ​

3.4% TLF

at 2 year ​

Download brochure

Speak to the team

Our office is open Monday - Friday 8.30am - 5.00pm

Feel free to get in touch direct or leave us a message on the contact form and the team will get back to you

Phone

+44 (0) 1934 53 34 53

E-mail

enquiries@gapmedicalsolutions.com

Address

65 Bath Road, Stroud, Gloucestershire, GL5 3LA